News
Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...
The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...
Capricor Therapeutics said on Tuesday the U.S. Food and Drug Administration may not seek its outside experts' advice when ...
Stocktwits on MSN4d
Capricor Stock Slumps 16% On Report Of Key FDA Executive’s Removal, But Retail’s Hopeful About New 4-Year Deramiocel DataShares of Capricor Therapeutics (CAPR) tumbled 16% on Friday morning following reports that Nicole Verdun, director of the ...
The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...
Curay, who stepped into the role as the agency’s top drug regulator in January, is departing in July, according to an email ...
When Americans imagine the future, it always has a lot to do with flying cars, robot housekeepers, and just about anything ...
Nicole Verdun, MD, super office director of the FDA’s Office of Therapeutic Products (OTP) and her deputy Rachael Anatol, PhD ...
Vinay Prasad—the controversial head of vaccine regulation at the US Food and Drug Administration (FDA)—has been named FDA chief medical and scientific officer.1 Traditionally separate roles, his new ...
Pharmaceutical Technology on MSN4d
FDA cell and gene therapy director exit increases ‘volatility’ for sectorNicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...
Capricor stock drops as FDA cancels advisory meeting on Duchenne therapy; leadership changes and regulatory tensions fuel uncertainty.
The Alliance for Regeneration Medicine (ARM), a trade group that represents more than 400 members companies across 25 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback